chr2-237324816-T-C
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_004369.4(COL6A3):c.9494-2A>G variant causes a splice acceptor change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000341 in 1,613,276 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004369.4 splice_acceptor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A3 | NM_004369.4 | c.9494-2A>G | splice_acceptor_variant | ENST00000295550.9 | NP_004360.2 | |||
COL6A3 | NM_057166.5 | c.7673-2A>G | splice_acceptor_variant | NP_476507.3 | ||||
COL6A3 | NM_057167.4 | c.8876-2A>G | splice_acceptor_variant | NP_476508.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL6A3 | ENST00000295550.9 | c.9494-2A>G | splice_acceptor_variant | 1 | NM_004369.4 | ENSP00000295550 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 151992Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000363 AC: 9AN: 247944Hom.: 0 AF XY: 0.0000373 AC XY: 5AN XY: 134192
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461168Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 726838
GnomAD4 genome AF: 0.000230 AC: 35AN: 152108Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74376
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 15, 2024 | Canonical splice site variant with an unclear effect on protein function; Has not been previously published as pathogenic or benign to our knowledge - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Dec 28, 2020 | - - |
Bethlem myopathy 1A Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 22, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 576775). This variant has not been reported in the literature in individuals affected with COL6A3-related conditions. This variant is present in population databases (rs142546062, gnomAD 0.1%). This sequence change affects an acceptor splice site in intron 43 of the COL6A3 gene. While this variant is not anticipated to result in nonsense mediated decay, it likely alters RNA splicing and results in a disrupted protein product. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at